274 related articles for article (PubMed ID: 30033912)
1. Emerging Biomarkers and Therapeutic Pipelines for Chronic Spontaneous Urticaria.
Deza G; Ricketti PA; Giménez-Arnau AM; Casale TB
J Allergy Clin Immunol Pract; 2018; 6(4):1108-1117. PubMed ID: 30033912
[TBL] [Abstract][Full Text] [Related]
2. Biologics for the Use in Chronic Spontaneous Urticaria: When and Which.
Maurer M; Khan DA; Elieh Ali Komi D; Kaplan AP
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1067-1078. PubMed ID: 33685605
[TBL] [Abstract][Full Text] [Related]
3. Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.
Giménez-Arnau AM
Expert Opin Biol Ther; 2017 Mar; 17(3):375-385. PubMed ID: 28125304
[TBL] [Abstract][Full Text] [Related]
4. Potential blood biomarkers in chronic spontaneous urticaria.
Kolkhir P; André F; Church MK; Maurer M; Metz M
Clin Exp Allergy; 2017 Jan; 47(1):19-36. PubMed ID: 27926978
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria.
Kolkhir P; Altrichter S; Hawro T; Maurer M
Allergy; 2018 Apr; 73(4):940-948. PubMed ID: 29130488
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.
Ghazanfar MN; Holm JG; Thomsen SF
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1761-1767. PubMed ID: 29729103
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A
Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879
[TBL] [Abstract][Full Text] [Related]
8. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in Refractory Chronic Spontaneous Urticaria: An Encouraging Therapeutic Approach.
Combalia A; Losno RA; Prieto-González S; Mascaró JM
Skin Pharmacol Physiol; 2018; 31(4):184-187. PubMed ID: 29649806
[TBL] [Abstract][Full Text] [Related]
10. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of treatment efficacy in patients with chronic spontaneous urticaria.
Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F; González-Aveledo L
Eur Ann Allergy Clin Immunol; 2018 Jan; 50(1):5-9. PubMed ID: 29350016
[No Abstract] [Full Text] [Related]
12. Current challenges and controversies in the management of chronic spontaneous urticaria.
Asero R; Pinter E; Marra AM; Tedeschi A; Cugno M; Marzano AV
Expert Rev Clin Immunol; 2015; 11(10):1073-82. PubMed ID: 26174347
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severely recalcitrant chronic spontaneous urticaria: a discussion of relevant issues.
Wieder S; Maurer M; Lebwohl M
Am J Clin Dermatol; 2015 Feb; 16(1):19-26. PubMed ID: 25452254
[TBL] [Abstract][Full Text] [Related]
14. The Role of Interleukin 10 and 18 in Chronic Spontaneous Urticaria Pathogenesis in the Context of Angioedema Coexistence.
Moos Ł; Kapeluszna K; Okuniewicz R; Brzoza Z
J Interferon Cytokine Res; 2021 May; 41(5):172-176. PubMed ID: 34003678
[TBL] [Abstract][Full Text] [Related]
15. Emerging Therapies in Chronic Spontaneous Urticaria.
Min TK; Saini SS
Allergy Asthma Immunol Res; 2019 Jul; 11(4):470-481. PubMed ID: 31172716
[TBL] [Abstract][Full Text] [Related]
16. Biologics in Chronic Urticaria.
Bulkhi A; Cooke AJ; Casale TB
Immunol Allergy Clin North Am; 2017 Feb; 37(1):95-112. PubMed ID: 27886913
[TBL] [Abstract][Full Text] [Related]
17. Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.
Zazzali JL; Kaplan A; Maurer M; Raimundo K; Trzaskoma B; Solari PG; Antonova E; Mendelson M; Rosén KE
Ann Allergy Asthma Immunol; 2016 Oct; 117(4):370-377.e1. PubMed ID: 27424128
[TBL] [Abstract][Full Text] [Related]
18. Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria.
Giménez-Arnau AM; Toubi E; Marsland AM; Maurer M
J Eur Acad Dermatol Venereol; 2016 Jul; 30 Suppl 5():25-32. PubMed ID: 27286500
[TBL] [Abstract][Full Text] [Related]
19. D-Dimer Plasma Levels Parallel the Clinical Response to Omalizumab in Patients with Severe Chronic Spontaneous Urticaria.
Asero R; Marzano AV; Ferrucci S; Cugno M
Int Arch Allergy Immunol; 2017; 172(1):40-44. PubMed ID: 28219067
[TBL] [Abstract][Full Text] [Related]
20. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study.
Kocatürk E; Can PK; Akbas PE; Copur M; Degirmentepe EN; Kızıltac K; Singer R
J Dermatol Sci; 2017 Jul; 87(1):60-69. PubMed ID: 28314658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
